HPV | AVE | Histology status | Total | |||||
---|---|---|---|---|---|---|---|---|
 < CIN2 | CIN2 | CIN3+ | ||||||
n | % | n | % | n | % | n | ||
HPV 16+ | Precancer/cancer | 12 | 1.4 | 0 | 0.0 | 21 | 39.6 | 33 |
Indeterminate | 11 | 1.3 | 2 | 14.3 | 1 | 1.9 | 14 | |
Normal | 21 | 2.4 | 2 | 14.3 | 4 | 7.5 | 27 | |
No result* | 4 | – | 1 | – | 9 | – | 14 | |
Subtotal | 48 | 5.1 | 5 | 28.6 | 35 | 49.1 | 88 | |
HPV 18/45+ | Precancer/cancer | 10 | 1.2 | 1 | 7.1 | 6 | 11.3 | 17 |
Indeterminate | 13 | 1.5 | 0 | 0.0 | 3 | 5.7 | 16 | |
Normal | 23 | 2.7 | 0 | 0.0 | 0 | 0.0 | 23 | |
No result* | 1 | – | 0 | – | 5 | – | 6 | |
Subtotal | 47 | 5.3 | 1 | 7.1 | 14 | 17.0 | 62 | |
HPV 31/33/52/58+ | Precancer/cancer | 30 | 3.5 | 3 | 21.4 | 9 | 17.0 | 42 |
Indeterminate | 32 | 3.7 | 1 | 7.1 | 1 | 1.9 | 34 | |
Normal | 43 | 5.0 | 0 | 0.0 | 0 | 0.0 | 43 | |
No result* | 5 | – | 1 | – | 1 | – | 7 | |
Subtotal | 110 | 12.2 | 5 | 28.6 | 11 | 18.9 | 126 | |
HPV other HR+ | Precancer/cancer | 14 | 1.6 | 0 | 0.0 | 3 | 5.7 | 17 |
Indeterminate | 24 | 2.8 | 0 | 0.0 | 2 | 3.8 | 26 | |
Normal | 35 | 4.1 | 0 | 0.0 | 0 | 0.0 | 35 | |
No result* | 3 | – | 0 | – | 4 | – | 7 | |
Subtotal | 76 | 8.4 | 0 | 0.0 | 9 | 9.4 | 85 | |
HPV High risk− | Precancer/cancer | 90 | 10.4 | 2 | 14.3 | 2 | 3.8 | 94 |
Indeterminate | 176 | 20.4 | 0 | 0.0 | 1 | 1.9 | 177 | |
Normal | 330 | 38.2 | 3 | 21.4 | 0 | 0.0 | 333 | |
No result* | 33 | – | 0 | – | 0 | – | 33 | |
Subtotal | 629 | 69.0 | 5 | 35.7 | 3 | 5.7 | 637 | |
Total | Â | 910 | 100 | 16 | 100 | 72 | 100 | 998 |